Project 112 was the Department of Defense's classified program to test chemical and biological warfare agents in open-air environments between 1962 and 1973. Under the program's naval component — Project SHAD (Shipboard Hazard and Defense) — thousands of sailors were exposed to nerve agents including VX and sarin, biological agents including Q fever and tularemia, and chemical agents including mustard gas. Service members were not informed they were participating in weapons tests, were not provided adequate protective equipment, and were ordered not to discuss what they experienced. The full scope of Project 112 remained classified until investigative reporting and Congressional pressure forced partial declassification in 2002.
Project 112 was the Department of Defense's classified program to test chemical and biological warfare agents in operationally realistic environments. Running from 1962 to 1973, the program was designed to answer questions that laboratory research could not: How do nerve agents disperse in ocean environments? Can biological weapons incapacitate a ship's crew before detection? What concentrations of chemical agents are required to penetrate standard protective equipment?
To answer these questions, the military conducted at least 134 separate tests — though the full number may be higher. These tests exposed thousands of American service members to lethal and incapacitating agents including VX and sarin nerve agents, sulfur mustard (mustard gas), and biological weapons including Q fever and tularemia. Most participants were not informed they were involved in chemical or biological weapons tests. They were told they were testing detection equipment, participating in routine training, or evaluating protective gear.
The program was managed by the Deseret Test Center, based at Dugway Proving Ground in Utah. The center coordinated tests across multiple locations including Pacific islands, Alaska, Hawaii, and aboard ships at sea. The naval component — Project SHAD (Shipboard Hazard and Defense) — conducted dozens of tests exposing an estimated 5,842 sailors to chemical and biological agents.
Project 112 represented a significant expansion of the military's chemical and biological weapons testing program. Earlier tests, including those at Edgewood Arsenal and Fort Detrick, had been conducted in controlled laboratory or small-scale field settings. Project 112 was designed to produce operational data: how agents behave in realistic combat conditions, how quickly they disperse, how long they remain effective, and what defensive measures work against them.
Project 112 operated in a regulatory gray zone. The Nuremberg Code, established in 1947 following Nazi medical experimentation trials, required voluntary informed consent for medical research on human subjects. The United States adopted these principles in theory but did not consistently apply them to military research. The Department of Defense maintained that soldiers could be ordered to participate in "hazardous duty" as part of military service — and that chemical and biological weapons testing fell under this category.
Service members who participated in Project 112 tests were not asked to provide informed consent. They were given orders. In most cases, they were not told they were being exposed to chemical or biological weapons. After tests, many were ordered not to discuss what they had witnessed. This secrecy served two purposes: it maintained operational security for classified weapons programs, and it insulated the military from accountability if participants developed health problems.
"We were told we were testing equipment. They didn't say anything about nerve gas. We were out on the deck when the planes came over. Some of the guys got really sick. They took them below and we never saw them again on that deployment."
Anonymous Project SHAD participant — Senate Veterans' Affairs Committee testimony, 2003The lack of informed consent was not unique to Project 112. During the same period, the Army was conducting parallel chemical weapons tests at Edgewood Arsenal, where approximately 7,000 soldiers were exposed to agents including LSD, BZ (a hallucinogenic incapacitant), and various nerve agents. At Fort Detrick and Pine Bluff Arsenal, researchers were testing weaponized biological agents. Across these programs, the pattern was consistent: service members were ordered to participate, not informed of risks, and not systematically monitored for long-term health effects.
This approach was justified by military necessity. Program advocates argued that the Soviet Union and China possessed extensive chemical and biological weapons capabilities. To develop effective defenses, the military needed realistic test data. Laboratory research was insufficient. The only way to understand how agents behave in operational conditions was to test them in those conditions — which meant exposing service members.
Project 112 tests fell into several categories. Chemical agent tests examined how nerve agents and vesicants disperse and persist in different environments. Biological agent tests assessed the infectivity and incapacitating effects of weaponized bacteria and toxins. Defensive tests evaluated detection equipment, protective gear, and decontamination procedures. Many tests combined multiple objectives.
A typical Project SHAD test followed a standard protocol. Naval vessels would be positioned in a designated test area — often in the Pacific Ocean or off the coast of Hawaii or Alaska. Aircraft would approach the ships and release chemical or biological agents from spray tanks. The agents would drift over the ships, exposing sailors positioned on deck. Some crew members would be provided protective equipment; others would not, to assess exposure levels and physiological effects.
During the test, medical personnel would monitor participants for symptoms. Air sampling equipment would measure agent concentrations. After the test, decontamination procedures would be evaluated. In some cases, sailors showing symptoms would be taken to medical facilities. Medical records from these examinations were often classified and not provided to the service members themselves.
Land-based tests followed similar protocols. Agents would be released from aircraft, rockets, or ground-based generators. Soldiers would be positioned downwind to assess exposure. The Deseret Test Center conducted tests in Utah, Alaska, Hawaii, and on Pacific islands including Johnston Atoll and Eniwetok Atoll. Some tests used live agents; others used simulants — substances believed to behave like warfare agents but supposedly less dangerous.
The simulant assumption proved problematic. Bacillus globigii and Serratia marcescens — bacteria used extensively in Project 112 tests as simulants for anthrax and other biological weapons — were long considered harmless. Later research established that both can cause infections in humans, particularly those with compromised immune systems. Zinc cadmium sulfide, a fluorescent particle used to track agent dispersal, contains cadmium — a toxic heavy metal and known carcinogen. Veterans exposed to these simulants have developed health problems, but the VA initially refused to recognize simulant exposure as potentially harmful.
Operation Flower Drum, conducted in 1964, exemplifies Project SHAD methodology. In this test series, aircraft released weaponized Q fever bacteria over naval vessels in the Pacific. Q fever causes severe incapacitating illness characterized by high fever, severe headache, and pneumonia. The bacteria is highly infectious — a single organism can cause disease. Hundreds of sailors were exposed. Medical personnel monitored them for symptoms but did not inform them they had been exposed to a biological weapon.
Some sailors developed Q fever. They were treated with antibiotics but not told what had caused their illness. The exposure was not noted in their service medical records. Decades later, when some of these veterans developed chronic Q fever complications including endocarditis (heart valve infection), they had no documentation to support a service connection claim.
Operation Autumn Gold, conducted in 1963, tested the effectiveness of VX nerve agent against ships. Aircraft sprayed VX over vessels positioned in the Pacific. Sailors on deck were exposed to concentrations ranging from sub-lethal to potentially lethal levels. Some wore protective equipment; others did not. Medical personnel monitored symptoms including vision problems (VX causes severe miosis — pinpoint pupils), respiratory distress, muscle fasciculation, and loss of consciousness.
The test demonstrated that even brief VX exposure caused measurable physiological effects in most exposed sailors. However, the long-term consequences of low-level VX exposure were not systematically studied. Veterans from Autumn Gold have reported chronic neurological symptoms including tremors, peripheral neuropathy, cognitive impairment, and chronic fatigue. Establishing causation decades after exposure is difficult, but the symptom pattern is consistent with organophosphate neurotoxicity.
"The DoD has identified only 28 tests out of at least 134 that were conducted under Project 112. The information provided has been incomplete and, in some cases, inaccurate. Service members who participated in these tests deserve full disclosure."
Government Accountability Office — Report GAO-04-410, March 2004Project 112 remained classified for nearly three decades after it ended in 1973. Veterans who suspected their health problems were related to chemical or biological weapons exposure had no official confirmation that such tests had occurred. When they filed VA disability claims, they were routinely denied for lack of documentation.
In the 1990s, some veterans began connecting with each other, comparing experiences and realizing they had participated in the same program. They contacted members of Congress. Senator John D. Rockefeller IV of West Virginia took up their cause, beginning an investigation in the late 1990s.
The breakthrough came in September 2000, when CBS News broadcast an investigation revealing the existence of Project SHAD. The story featured interviews with Navy veterans and cited partially declassified documents obtained through Freedom of Information Act requests. When CBS contacted the Pentagon, officials initially denied the program existed. After being presented with documentary evidence, they acknowledged that "some testing may have occurred" but claimed records were incomplete.
Congressional pressure intensified. In 2002, the Department of Defense established a Project SHAD declassification effort and created a website to release information. The initial release acknowledged 28 tests and provided fact sheets with basic information about test locations, dates, and agents used. However, the information was incomplete. Many fact sheets did not list all agents used in specific tests. Personnel rosters were not provided. Medical monitoring data was not released.
A 2004 Government Accountability Office investigation found that the Pentagon had understated the scope of Project 112. The GAO identified at least 134 separate tests — nearly five times the number the Defense Department had acknowledged. The investigation also found that information provided about the 28 acknowledged tests contained significant inaccuracies and omissions.
The long-term health effects of exposure to chemical and biological warfare agents are well-documented in toxicological and epidemiological literature. Nerve agent exposure causes both acute effects (respiratory failure, convulsions) and chronic neurological damage. Studies of Japanese civilians exposed to sarin in the 1995 Tokyo subway attack show persistent cognitive impairment, peripheral neuropathy, and post-traumatic stress disorder years after exposure.
Mustard gas exposure causes immediate skin and respiratory damage and significantly elevated cancer risk decades later. Studies of World War I veterans exposed to mustard gas found elevated rates of lung, laryngeal, and skin cancers 40 to 50 years after exposure. The mechanism is well understood: mustard gas is a DNA alkylating agent that causes mutations leading to cancer.
Q fever can cause chronic complications including endocarditis, chronic fatigue syndrome, and post-Q fever fatigue syndrome. Approximately 1-5% of Q fever patients develop chronic Q fever, which can be fatal if untreated. Tularemia, another biological agent tested in Project 112, can cause chronic complications including arthritis, meningitis, and lung damage.
These health effects are established in peer-reviewed medical literature. The causal connection between chemical and biological agent exposure and specific diseases is not disputed scientifically. However, establishing service connection for individual veterans requires documentation proving exposure occurred during military service. This is where Project 112 participants faced an insurmountable barrier: the military had classified or destroyed the exposure records.
When Project 112 veterans began filing disability claims in the 1990s and early 2000s, the VA routinely denied them. The standard denial stated that without official military records documenting exposure, service connection could not be established. This created a catch-22: veterans knew they had been exposed but could not prove it because the military refused to release exposure records.
Even after the Pentagon partially acknowledged Project 112 in 2002, the VA continued denying many claims. The agency argued that the released information was insufficient to prove individual exposure. A veteran might prove he was assigned to a ship that participated in a Project SHAD test, but without a personnel roster showing he was on deck during agent release, the VA would not presume exposure.
Congressional pressure eventually forced the VA to change its approach. In 2007, the VA added specific conditions to the presumptive service connection list for veterans who participated in certain Project 112 tests. These conditions included specific cancers (lung, laryngeal, esophageal) linked to mustard gas exposure and neurological conditions linked to nerve agent exposure.
However, the presumption applied only to tests the Pentagon had officially acknowledged — and only if the veteran could prove participation in a specific acknowledged test. Veterans who participated in tests that remain classified or unacknowledged received no presumptive benefits. Veterans who could not prove participation in specific tests — because personnel records were inadequate or destroyed — also received no benefits.
No military or civilian officials have been held accountable for Project 112. No one was prosecuted for conducting non-consensual human experimentation. No one was disciplined for destroying exposure records. No formal apology has been issued to exposed veterans.
The Pentagon's position has been that Project 112 was conducted under the legal and ethical standards that existed at the time. Military officials argue that the Nuremberg Code's informed consent requirement did not clearly apply to military hazardous duty. They note that courts have consistently held that service members cannot sue the government for injuries arising from military service — the "Feres doctrine" established by the Supreme Court in 1950.
Critics argue this misrepresents both the law and the ethics of the period. The Nuremberg Code was understood to prohibit non-consensual experimentation regardless of the subject's status. The Department of Defense had its own regulations requiring informed consent for research involving human subjects — though these regulations were often ignored or circumvented.
The destruction or classification of exposure records appears particularly indefensible. Even if one accepts the argument that Project 112 testing was legally and ethically permissible under military authority, the failure to maintain medical records and notify exposed personnel of potential long-term health risks served no legitimate purpose. It denied veterans access to medical care and disability benefits they had earned through service.
Project 112 was not an isolated program. It was part of a broader pattern of military human subjects research during the Cold War. The Army conducted chemical weapons tests at Edgewood Arsenal on approximately 7,000 soldiers. The CIA ran MKUltra, exposing unwitting subjects to LSD and other experimental drugs. The Navy conducted radiation experiments on sailors. The Army released biological simulants over American cities including San Francisco, Minneapolis, and St. Louis to study dispersion patterns.
This research was driven by Cold War strategic concerns. The Soviet Union and China possessed extensive chemical and biological weapons programs. American military planners believed they needed comparable capabilities — both offensive weapons and defenses against enemy weapons. Developing these capabilities required testing on humans. The alternative — relying on animal studies and theoretical models — was considered operationally inadequate.
The ethical calculation was utilitarian: the health risks to a few thousand test subjects were outweighed by the national security benefit of improved chemical and biological defense capabilities that could protect millions in the event of war. This calculation did not account for the test subjects' lack of consent, the inadequacy of medical monitoring, or the systematic denial of medical care and benefits when health problems emerged decades later.
"Project 112 testing was conducted to develop information on the effectiveness of chemical and biological weapons and defensive measures. The testing was consistent with the standards and practices of the time."
Department of Defense — Official Statement on Project 112 Declassification, May 2002Significant information about Project 112 remains classified or has been destroyed. The full list of tests has not been released. Complete personnel rosters do not exist or have not been disclosed. Medical monitoring data from many tests has not been provided to veterans or researchers. The long-term health outcomes of exposed service members have not been systematically studied.
The Pentagon maintains that it has released all available information about Project 112. However, GAO investigations and congressional inquiries have repeatedly found additional documents and test records after the Pentagon claimed no further information existed. This pattern suggests either that the Defense Department's archive search was inadequate or that officials have chosen to withhold information.
Some information may be genuinely lost. The military's document retention policies during the 1960s and 1970s called for destroying many types of records after a specified period. Personnel records, test reports, and medical files may have been destroyed in accordance with these policies. However, this explanation is undermined by the fact that the military maintained detailed records of equipment, supplies, and financial expenditures from the same period while claiming it cannot document human exposures.
Project 112 represents a case study in the tension between government secrecy and democratic accountability. The program was conducted in secret, with participants ordered not to discuss it. When veterans sought information decades later, they were told records did not exist or were classified for national security reasons. When journalists and congressional investigators obtained evidence that the program existed, the Pentagon initially denied it. When denial became untenable, the Pentagon acknowledged a fraction of the program and claimed complete disclosure.
This pattern — initial denial, minimal acknowledgment, claims of complete disclosure, followed by revelations of additional withheld information — has repeated across multiple Cold War-era military and intelligence programs. It suggests that classified programs create institutional incentives for continued secrecy even after the original justification for classification has expired. Officials who acknowledge past wrongdoing risk legal liability, political embarrassment, and damage to institutional credibility. The result is a system in which transparency requires external pressure — investigative journalism, congressional investigation, and litigation — rather than voluntary disclosure.
Project 112 ended in 1973, but its implications remain current. Thousands of veterans continue seeking medical care and disability benefits for conditions they believe are related to chemical and biological weapons exposure. Many have died without ever receiving acknowledgment of their exposure or compensation for service-connected disabilities.
The program also raises questions about current military human subjects research. The Department of Defense continues to conduct research involving service members. Current regulations require informed consent and independent review board approval. However, these regulations contain exceptions for "combat-related" research and allow consent to be waived in certain circumstances. Whether current practices adequately protect service members' rights remains contested.
Project 112 also informs debates about chemical and biological weapons policy. The United States ratified the Biological Weapons Convention in 1975 and the Chemical Weapons Convention in 1997, committing to never develop, produce, or stockpile such weapons. However, both treaties permit defensive research. The line between defensive research and offensive weapons development can be ambiguous. Project 112 demonstrates that "defensive" programs can involve extensive human exposure to warfare agents under conditions that differ from weapons development primarily in terminology.
The program's legacy is institutional distrust. Veterans who participated in Project 112 learned that their government would expose them to lethal agents without consent, conceal that exposure for decades, and then deny them medical care and benefits. That betrayal extends beyond the immediate victims to their families and to other veterans who recognize that what happened to Project 112 participants could happen to them.